Adjuvant immunotherapy in superficial bladder cancer
Morales, A.
National Cancer Institute Monograph 49: 315-319
1978
ISSN/ISBN: 0083-1921 PMID: 748787 Document Number: 138017
The use of BCG as an intracavitary form of immunotherapy in human bladder cancers is discussed. The result of a clinical trial in which BCG is administered in the treatment of human bladder cancers is reported. Possible uses of this tumor model in the study of immunotherapy employing BCG are suggested.
Document emailed within 1 workday
Related Documents
Schmitz-Dräger, B.J.; Schattka, S.O.; Ebert, T. 1993: Immunotherapy of superficial bladder cancer Der Urologe. Ausg. a 32(5): 374-381Schreinemachers, L.; Van der Meyden, A.; Steerenberg, P.; Feitz, W.; Groothuis, D.; De Jong, W.; Debruyne, F. 1987: BCG-RIVM: a new BCG preparation for intravesical immunotherapy of superficial bladder cancer Chemioterapia: International Journal of the Mediterranean Society of ChemoTherapy 6(2 Suppl): 713-716
Van der Meijden, A.P. 1992: New approaches to intravesical chemo-immunotherapy in superficial bladder cancer Progress in Clinical and Biological Research 378: 95-101
Flamm, J.; Grof, F. 1986: Adjuvant topical chemotherapy with cisplatin in superficial bladder cancer Der Urologe. Ausg. a 25(1): 48-50
Tubaro, A.; Stoppacciaro, A.; Velotti, F.; Bossola, P.C.; Cusumano, G.; Vicentini, C.; De Carli, P.; Ruco, L.; Santoni, A.; Cancrini, A. 1995: Local immunotherapy of superficial bladder cancer by intravesical instillation of recombinant interleukin-2 European Urology 28(4): 297-303
De Boer, E.C.; De Jong, W.H.; Steerenberg, P.A.; Van der Meijden, A.P.; Aarden, L.A.; Debruyne, F.M.; Ruitenberg, E.J. 1991: Leukocytes and cytokines in the urine of superficial bladder cancer patients after intravesical immunotherapy with bacillus Calmette-Guerin In Vivo 5(6): 671-677
Cockett, A.T.; Merguerian, P.A.; di Sant'Agnese, P.A.; Wheeless, L.L. 1989: Immunotherapy for the treatment of superficial and infiltrative bladder carcinoma Progress in Clinical and Biological Research 303: 455-462
Herr, H.W.; Kemeny, N.; Yagoda, A.; Whitmore, W.F. 1978: Poly I:C immunotherapy in patients with papillomas or superficial carcinomas of the bladder National Cancer Institute Monograph 49: 325
Kotake, T.; Koyanagi, T.; Akaza, H.; Shimazaki, J.; Ito, H.; Hosaka, M.; Okajima, E.; Saito, Y.; Miyanaga, N.; Kuroda, M.; Hirao, Y. 1998: Results of clinical study with epirubicin hydrochloride injectable solution for superficial bladder cancer. IMI28 Injectable Solution Study Group for Superficial Bladder Cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 25(8): 1189-1195
Iantorno, R.; Nicolai, M.; Cipollone, G.; Di Federico, G.; Tenaglia, R. 1997: Role of MCP-1 chemokine in the response of monocytes of patients with superficial tumors of the bladder treated with BCG immunotherapy Archivio Italiano di Urologia Andrologia: Organo Ufficiale di Societa Italiana di Ecografia Urologica e Nefrologica 69(Suppl 1): 71-72
Iturralde Codina, A.; Beyríe Tamayo, W.; Gozá León, F.; Muñoz, Y.I. 2004: Bacillus Calmette Guerin as adjuvant treatment for superficial bladder tumors using two different therapeutic schemes Archivos Espanoles de Urologia 57(6): 606-618
Flam, T.A.; Chopin, D.K.; Leleu, C.; Abbou, C.C.; Steg, A.; Deslignères, S.; Boccon-Gibod, L. 1990: Immunohistochemical markers defined by monoclonal antibodies and response to bacillus Calmette-Guérin endovesical immunotherapy for superficial bladder tumors European Urology 17(4): 338-342
Punga-Maole, M.L.; Hubert, J.; Mangin, P. 1995: Bladder retraction, a complication of chemoprophylaxis of superficial bladder cancer using intravesical mitomycin C. Apropos of a case and review of the literature Progres en Urologie: Journal de l'Association Francaise d'Urologie et de la Societe Francaise d'Urologie 5(4): 580-585
Colombo, R. 2006: Only an overall 15% net benefit emerges in favour of adjuvant intravesical chemotherapy when compared to transurethral resection alone for the prevention of recurrences of superficial bladder tumors European Urology 50(2): 233-234
Tsukagoshi, S. 2003: ImmuCyst intravesical (freeze-dried preparation made from the connaught strain of Bacillus Calmette Guérin) for the treatment of superficial bladder cancer and carcinoma in situ of urinary bladder Gan to Kagaku Ryoho. Cancer and ChemoTherapy 30(7): 1027-1038
Kitahata, Y.; Ishii, K.J. 2017: Development and application of adjuvant immunotherapy for cancer Nihon Rinsho. Japanese Journal of Clinical Medicine 75(2): 329-333
Schlag, P.M. 1994: Adjuvant systemic chemo- or immunotherapy of colon cancer Der Chirurg; Zeitschrift für Alle Gebiete der Operativen Medizen 65(6): 503-508
Sager, C.C.; Benamran, D.A.; Wirth, G.; Iselin, C.E. 2015: New approaches for the treatment of superficial bladder cancer Revue Medicale Suisse 11(497): 2281-2284
Baselli, E.C.; Greenberg, R.E. 2000: Intravesical therapy for superficial bladder cancer Oncology 14(5): 719
Böhle, A. 1994: Superficial bladder cancer. Open questions Der Urologe. Ausg. a 33(6): 536-539